Case File
efta-02474293DOJ Data Set 11OtherEFTA02474293
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02474293
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
jeffrey E. <[email protected]>
Sent:
Thursday, January 28, 2016 5:33 PM
To:
Melanie Spinella
Subject:
Re: FW: MRA/Epstein Letter and Invoice
yes it gets paid end of jan, with pleasure
=div class="gmail_extra">
On Thu, Jan 28, 2=16 at 12:28 PM, Melanie Spinella
[mailt
Not sure if you ever r=ceived the original.
</=pan>
From: Lauren L=iman
Sent: Thursday, January 28, 2016 12:06 PM
To: Melanie Spinella
Subject: MRA/Epstein Letter and Invoice
Attached and below is invoice and letter=from MRA Acting CEO Margaret Anderson to Jeffrey Epstein for his
$225,000 =015 MRA gift.
Thank you!
-L
January 28, 2016
=C2
=AO
=C2
=AO
=C2
=AO
=C2
Attn: Jeffrey Epstein
Jeffrey@jef=reyepstein.org <mailto:[email protected]>
Jeffrey Epstein VI Foundation
6100 Red Hook Quarters, Suite B-3
St. Thomas, Virgin Islands 00802.1348
Dear Mr. Epstein:
EFTA_R1_01586941
EFTA02474293
We are so grateful for y=ur continued support of our work at the Melanoma Research Alliance (MRA). =e were
delighted to receive your commitment to MRA's biennial bene=it dinner at Sotheby's to support MRA's research
portfolio.
More than 200 supporters joined us in celebrating th= progress taking place in the field of melanoma research
during our benefi= dinner last month. It truly was a wonderful night, as we honored the scie=tists and doctors who are
dedicated to defeating this disease, and also raised $5.8 million. As you know, 100%=of all funds raised go directly to
support MRA's research program.=u>
Please allow this letter to serve as confirmation of=your pledge for $225,000 for a Young Investigator Award.
The Young Investigator Award program aims to at=ract early career scientists with novel ideas into melanoma research,
ther=by recruiting and supporting the next generation of melanoma scientists.
=C2
Since we began our work, we have seen dramatic progr=ss in the field, with 11 new therapies coming to market
for patients with =elanoma — including three in the last month! MRA has been at the f=refront of some of the most
promising research, providing critical funding to elevate the pace of discovery. The impact is=being felt throughout the
field of oncology.
Enclosed please find an invoice for your commitment.=Please contact Logan Kastner, Director of Development
and Marketing, at <tel:%28202%29%20336-8944> or Ikastner@=ureMelanoma.org
<mailto:[email protected]> , with any questions.
At the Melanoma Research Alliance, we are committed =o funding the best research and brightest minds
throughout the world. With=your support, we will continue to change the field for all those impacted =y melanoma.
With sincere appreciation,
Margaret Anderson
Acting President & CEO=/u>
This email and any files transmitted with it are confidential and intended =olely for the person or entity to whom
they are addressed and may contain =onfidential and/or privileged material. Any review, retransmission, dissem=nation
or other use of, or taking of any action in reliance upon this information by persons or entities oth=r than the intended
2
EFTA_R1_01586942
EFTA02474294
recipient is prohibited. If you have received this ema=l in error please contact the sender and delete the material from
any comp=ter. Apollo Global Management, LLC
please =ote
The information contained in this communication is confiden=ial, may be attorney-client privileged, may constitute
inside informati=n, and is intended only for the use of the addressee. It is the propert= of JEE Unauthorized use,
disclosure or copying of this communica=ion or any part thereof is strictly prohibited and may be unlawful. If =ou have
received this communication in error, please notify us immediatrly by return e-mail or by e-mail to
[email protected] <mailto:jeevacation@gmail=com> , and destroy this comm=nication and all copies thereof,
including all attachments. copyright -=11 rights reserved
3
EFTA_R1_01586943
EFTA02474295
Technical Artifacts (8)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Phone
2474293Phone
2474294Phone
2474295Phone
336-8944Phone
802.1348Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.